We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Algorithm Aids Decision on Pneumonia Hospitalization

By HospiMedica staff writers
Posted on 07 Jul 2006
A clinical pathway algorithm has been developed that enables doctors to decide when nursing home residents with pneumonia can be treated in the nursing home and when they should be treated in a hospital.

To test the safety and feasibility of the clinical pathway algorithm, researchers from McMaster University (Hamilton, Ontario, Canada) selected ten nursing homes that were randomly assigned to use the clinical pathway, while other homes followed their usual care practices. More...
In either case, when a patient exhibited symptoms of a lower respiratory tract infection, the staff at the nursing home would obtain chest x-rays using a mobile unit. These were the patients who were eligible for inclusion in the study.

A nurse would then determine if the patients met five criteria. They could eat and drink, had a pulse of no more than 100/min, a respiratory rate of < 30/min, systolic blood pressure of 90 mm Hg or higher, and oxygen saturation of at least 92% (90% or more for residents with chronic obstructive pulmonary disease, or COPD). If any one of those five criteria was not met, the algorithm stipulated that the patient be transferred to a hospital. Otherwise, the patient would remain in the nursing home and be treated with levofloxacin 500 mg orally for 10 days and hypodermoclysis if dehydrated.

The researchers followed a total of 327 patients in the clinical pathway group and 353 in the usual care group. Thirty-four residents in the algorithm group (10%) and 76 (22%) in the usual care group were hospitalized. Based on their symptoms, 18 (24%) of those in the usual care group who had been hospitalized would have remained in the nursing home if the protocol had been followed. The mortality rates were similar between groups. The results were reported in the June 7, 2006, edition of the Journal of the American Medical Association (JAMA).



Related Links:
McMaster University

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
MRI System
nanoScan MRI 3T/7T
LED Surgical Lamp
ACEMST35/57
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.